Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

Add To Watchlist

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > What we need to know is...

View:

Post by prophetoffactz on Dec 22, 2022 8:50am

What we need to know is...

Why is there preclinical data being presented in Q2 for Hunter given the data presented to date. Is there something new and improved to take on Denali head-to-head and address risks of gene-therapy.
Does it improve Biodexa's standing for LSDs more generally?

113

Comment

Comment by prophetoffactz on Dec 22, 2022 9:05am

May Orfali is still on BTI's Medical Advisory Board according to BTI's website. She is also CMO of Sigilon. Unlike xB3 to our knowledge is she is helping to develop functional cures for LSDs with Sigilon? Here's the last info from last month: Sigilon is optimizing its MPS-1 program to penetrate the blood brain barrier to address neurological manifestations, as well as ...more

Comment